Andrew Grieve is the CEO of Zenabis and he joined Business of Cannabis to talk about their agreement to grow Tantalus Labs genetics on contract as well as their stock offering to current shareholders – which has been the topic of conversation among those that follow publicly traded cannabis companies.
Upcoming US Farm Bill Will ‘Promote Hemp Farming’, but Proposals So Far Fail to Address Intoxicating Substances
Both US Democrat and Republicans have put forward their proposals for the reauthorization of the 2024 Farm Bill, which covers...